A unique blend of forum and network, the Cardiovascular (CV) Team Member Section and Leadership Council is advancing ACC's efforts to identify and address gaps in areas of professional importance to ...

I am so honored to serve as the ACC WIC Leadership Council and Section Chair for 2022 to 2025. I am dedicated to enhancing our profession by engaging, preparing, and promoting women in leadership, ...

All activities are now available on ACC's online course, Navigating Cardiac PET Imaging: Clinical Advantages, Barriers and Cutting-Edge Applications. The free course includes eight lessons that review ...

CONSULTING FEES/HONORARIA: Novo Nordisk Inc.(MODEST), Edwards Lifesciences(MODEST) SPEAKER'S BUREAU: Abbott Vascular(MODEST), Edwards Lifesciences(MODEST), MSD(MODEST ...

Studies in all JACC journals are embargoed until they are published online. The chart below details the general embargo time and day for each journal; however, these dates are subject to change and ...

Join a community dedicated to innovative cardiovascular care, where every role contributes to our mission of transforming heart health. Explore opportunities that not only advance your career but also ...

A new clinical guideline released by the ACC and the American Heart Association includes new evidence and updated recommendations for managing patients with acute ...

According to a new study published in JACC, there is a strong dose-response relationship between cigarette smoking and three different domains of subclinical cardiovascular markers: inflammation, ...

The American College of Cardiology (ACC) has created practical point-of-care guidance, in the form of an Infographic and a Pocket Guide, to address common clinical questions and challenges regarding ...

The Heart Valve Collaboratory has proposed a framework to standardize best practices for using multimodality imaging in transcatheter valve failure (TVF) following transcatheter aortic valve ...

Treatment of severe heart failure (HF) across the spectrum of LVEF with the SGLT2 inihbitor dapagliflozin appeared to be safe and effective in reducing the risk of cardiovascular death or worsening HF ...

A 50-year-old woman presents to the clinic with worsening fatigue, dyspnea on exertion, and peripheral edema over the previous 3 months. She has a history of hypertension and nonischemic dilated ...